Cyclomics Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- (Cancelled)
- Latest Deal Amount
-
$3.05M
- Investors
-
3
Cyclomics General Information
Description
Operator of molecular diagnostic technology intended to support cancer detection and intraoperative tumour classification. The company offers nanopore sequencing, circulating tumour DNA analysis, DNA methylation profiling, and deep learning-based tumour classification tools, enabling researchers, pathologists, and surgical teams to perform non-invasive cancer monitoring and real-time molecular diagnostic assessment.
Contact Information
Website
www.cyclomics.com(Operating Subsidiary)
Corporate Office
- Matrix ONE building
- Science Park 301
- 1098 XH Amsterdam
- Netherlands
Corporate Office
- Matrix ONE building
- Science Park 301
- 1098 XH Amsterdam
- Netherlands
Cyclomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 07-Jan-2026 | $3.05M | Cancelled | Generating Revenue | ||
| 7. Accelerator/Incubator | 07-Oct-2024 | Completed | Generating Revenue | |||
| 6. Merger/Acquisition | 01-Feb-2024 | Completed | Generating Revenue | |||
| 5. Seed Round | 03-Mar-2023 | Completed | Generating Revenue | |||
| 4. Merger/Acquisition | 13-Feb-2024 | Cancelled | Generating Revenue | |||
| 3. Grant | 01-Mar-2019 | Completed | Generating Revenue | |||
| 2. Grant | 01-Nov-2017 | $29.4K | Completed | Generating Revenue | ||
| 1. University Spin-Out | 01-Nov-2017 | Completed | Generating Revenue |
Cyclomics Patents
Cyclomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025127927-A1 | Method for sequencing nucleic acid molecules and related methods | Inactive | 12-Dec-2023 |
Cyclomics Signals
Cyclomics Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Horizon 2020 | Government | |||
| LifeSciences@Work | Accelerator/Incubator | |||
| UMC Utrecht | University |
Cyclomics FAQs
-
When was Cyclomics founded?
Cyclomics was founded in 2017.
-
Where is Cyclomics headquartered?
Cyclomics is headquartered in Amsterdam, Netherlands.
-
What is the size of Cyclomics?
Cyclomics has 10 total employees.
-
What industry is Cyclomics in?
Cyclomics’s primary industry is Biotechnology.
-
Is Cyclomics a private or public company?
Cyclomics is a Private company.
-
What is Cyclomics’s current revenue?
The current revenue for Cyclomics is .
-
Who are Cyclomics’s investors?
Horizon 2020, LifeSciences@Work, and UMC Utrecht have invested in Cyclomics.
-
When was Cyclomics acquired?
Cyclomics was acquired on 07-Jan-2026.
-
Who acquired Cyclomics?
Cyclomics was acquired by Lunai Bioworks.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process